Sulforaphane almost completely prevents doxorubicin (chemotherapy)-induced cardiac oxidative stress, inflammation and fibrosis in rats.
“Our findings not only provide further insight into DOX-induced cardiotoxicity, but especially demonstrate SFN action through the Keap1/Nrf2 signaling pathway for countering cardiac damage.”